AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35934778 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg pitavastatin
Number of subjects: 12413
Study 35934778 — intervention group
Group type: COMPARATOR
Intervention: 1 mg pitavastatin
Number of subjects: 12413
Study 35152194 — intervention group
Group type: EXPERIMENTAL
Intervention: Licorice mucoadhesive film
Number of subjects: 60
Study 35152194 — intervention group
Group type: COMPARATOR
Intervention: Placebo mucoadhesive film
Number of subjects: 60
Study 33370131 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-cost implementation supports (LC)
Number of subjects: 200
Study 33370131 — intervention group
Group type: COMPARATOR
Intervention: Expert MATCH consultation plus lower-cost supports (CLC)
Number of subjects: 200
Study 35287519 — intervention group
Group type: EXPERIMENTAL
Intervention: Criminal context warned feigners
Number of subjects: 145
Study 35287519 — intervention group
Group type: COMPARATOR
Intervention: Truth tellers
Number of subjects: 145
Study 35287519 — intervention group
Group type: EXPERIMENTAL
Intervention: Criminal context feigners
Number of subjects: 145
Study 35287519 — intervention group
Group type: EXPERIMENTAL
Intervention: Civil context feigners
Number of subjects: 145
Study 35287519 — intervention group
Group type: EXPERIMENTAL
Intervention: Civil context warned feigners
Number of subjects: 145
Study 32356559 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Number of subjects: 158
Study 32356559 — intervention group
Group type: COMPARATOR
Intervention: Healthy older sedentary individuals (SR)
Number of subjects: 158
Study 32356559 — intervention group
Group type: COMPARATOR
Intervention: Healthy older active individuals (HA)
Number of subjects: 158
Study 32356559 — intervention group
Group type: COMPARATOR
Intervention: Healthy older sedentary individuals (HS)
Number of subjects: 158
Study 34038208 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory continuous nursing using the WeChat platform
Number of subjects: 78
Study 34038208 — intervention group
Group type: COMPARATOR
Intervention: Regular care (Control)
Number of subjects: 78
Study 33177134 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency telerehabilitation speech and language therapy (teleSLT)
Number of subjects: 100
Study 33177134 — intervention group
Group type: COMPARATOR
Intervention: Telerehabilitative cognitive training (teleCT)
Number of subjects: 100
Study 35059864 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone-modifying agents (BMA)
Number of subjects: 162
Study 34638428 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright white light intervention (BWL)
Number of subjects: 166
Study 34638428 — intervention group
Group type: COMPARATOR
Intervention: Dim white light comparison (DWL)
Number of subjects: 166
Study 34480887 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS associated with functional exercise
Number of subjects: 31
Study 34480887 — intervention group
Group type: COMPARATOR
Intervention: Sham-tDCS associated with functional exercise
Number of subjects: 31
Study 32957077 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional group (TRG) - 6 sets × 5 repetitions with 3 minutes of interset rest.
Number of subjects: 35
Study 32957077 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest redistribution group (RRG) - 1 set × 30 repetitions with 31 seconds of interrepetition rest.
Number of subjects: 35
Study 32957077 — intervention group
Group type: COMPARATOR
Intervention: Control group - no intervention.
Number of subjects: 35
Study 32147484 — intervention group
Group type: EXPERIMENTAL
Intervention: TDF + pegIFN + REP 2139 or REP 2165
Number of subjects: 40
Study 32147484 — intervention group
Group type: COMPARATOR
Intervention: TDF + pegIFN
Number of subjects: 40
Study 35084526 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapeutic prehabilitation (pERACS)
Number of subjects: 107
Study 35084526 — intervention group
Group type: COMPARATOR
Intervention: Normal physical activities (Control)
Number of subjects: 107
Study 33227448 — intervention group
Group type: COMPARATOR
Intervention: Control RCTs (n = 13, 115, 71, and 36 trials)
Number of subjects: 373
Study 33227448 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs with publication integrity concerns (n = 151 and 35 trials)
Number of subjects: 373
Study 33227448 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-arm RCTs with publication integrity concerns
Number of subjects: 373
Study 32466396 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction (BFR)
Number of subjects: 10
Study 32466396 — intervention group
Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 10
Study 35213721 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete reperfusion after PCI with TFG = 3
Number of subjects: 2606
Study 35213721 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal myocardial perfusion with TMPG = 3
Number of subjects: 2606
Study 35213721 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete vs. incomplete TFG in STEMI
Number of subjects: 2606
Study 35213721 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal vs. abnormal TMPG in NSTE-ACS
Number of subjects: 2606
Study 34657869 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Self-Care Support Program (PSCSP)
Number of subjects: 45
Study 34657869 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 45
Study 32506558 — intervention group
Group type: EXPERIMENTAL
Intervention: QuikFix (individualised personality-specific coping skills training)
Number of subjects: 398
Study 32506558 — intervention group
Group type: COMPARATOR
Intervention: MI (motivational interviewing)
Number of subjects: 398
Study 32506558 — intervention group
Group type: COMPARATOR
Intervention: AF/I (assessment feedback/information)
Number of subjects: 398
Study 32331914 — intervention group
Group type: EXPERIMENTAL
Intervention: Injectable antibiotics (primarily penicillins and cephalosporins)
Number of subjects: 5446
Study 32331914 — intervention group
Group type: EXPERIMENTAL
Intervention: Third-generation cephalosporins
Number of subjects: 5446
Study 32331914 — intervention group
Group type: EXPERIMENTAL
Intervention: Analgesics and insulin
Number of subjects: 5446
Study 32331914 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost of prescription and injectable drugs
Number of subjects: 5446
Study 35447934 — intervention group
Group type: EXPERIMENTAL
Intervention: Freshwater clam extract (FCE), 2 grams daily for 180 days
Number of subjects: 36
Study 35447934 — intervention group
Group type: COMPARATOR
Intervention: Placebo, 2 grams daily for 180 days
Number of subjects: 36
Study 34176420 — intervention group
Group type: EXPERIMENTAL
Intervention: Irritable Bowel Syndrome (IBS)
Number of subjects: 360194
Study 32664101 — intervention group
Group type: EXPERIMENTAL
Intervention: LIA (local infiltration analgesia)
Number of subjects: 0
Study 32664101 — intervention group
Group type: COMPARATOR
Intervention: ISB (interscalene nerve block)
Number of subjects: 0
Study 35710226 — intervention group
Group type: EXPERIMENTAL
Intervention: PILATES (12-week program at moderate intensity, 3x/week, 60-min sessions)
Number of subjects: 22
Study 35710226 — intervention group
Group type: COMPARATOR
Intervention: CONTROL
Number of subjects: 22
Study 33448753 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-driven cognitive rehabilitation (TCR)
Number of subjects: 32
Study 33448753 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized cognitive rehabilitation (CCR)
Number of subjects: 32
Study 33448753 — intervention group
Group type: COMPARATOR
Intervention: TCR
Number of subjects: 32
Study 34188114 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke lesions in the right putamen and internal capsules of both hemispheres
Number of subjects: 329
Study 34188114 — intervention group
Group type: EXPERIMENTAL
Intervention: Injuries of the cortico-spinal tracts
Number of subjects: 329
Study 34188114 — intervention group
Group type: EXPERIMENTAL
Intervention: Striato-capsular lesions
Number of subjects: 329
Study 32615659 — intervention group
Group type: EXPERIMENTAL
Intervention: Krocina™
Number of subjects: 40
Study 32615659 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 36451437 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational music intervention (twice-weekly group sessions for 8 weeks)
Number of subjects: 0
Study 36451437 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34370401 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity intervention group (assessments plus weekly sessions)
Number of subjects: 199
Study 34370401 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity control group (home-based assessments)
Number of subjects: 199
Study 34370401 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity intervention group
Number of subjects: 199
Study 32115450 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified group 2 (FG2) with 76 mg/100 g bovine lactoferrin (bLF)
Number of subjects: 108
Study 32115450 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified group 1 (FG1) with 38 mg/100 g bovine lactoferrin (bLF)
Number of subjects: 108
Study 32115450 — intervention group
Group type: COMPARATOR
Intervention: Control group (FG0) with no bovine lactoferrin (bLF)
Number of subjects: 108
Study 35397279 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal emotion regulation intervention
Number of subjects: 19
Study 35397279 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no manipulation of emotion regulation strategies)
Number of subjects: 19
Study 32507649 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet index score (PIS) incorporating high platelet count (PLT ≥350), high mean platelet volume (MPV ≥8.8), and low platelet distribution width (PDW <12.1)
Number of subjects: 1198
Study 32507649 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms based on the platelet index score (PIS) and clinicopathological features
Number of subjects: 1198
Study 35918295 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic polymer foam (EPF)
Number of subjects: 14
Study 35918295 — intervention group
Group type: COMPARATOR
Intervention: Endobronchial valve control group (EBV-CTRL)
Number of subjects: 14
Study 32019822 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial fibrillation screening device (AFSD)
Number of subjects: 1518
Study 32019822 — intervention group
Group type: COMPARATOR
Intervention: 12-lead ECG
Number of subjects: 1518
Study 34449490 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (group D)
Number of subjects: 61
Study 34449490 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil (group R)
Number of subjects: 61
Study 34215981 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal exposure to bisphenol A (BPA) measured in urinary concentration
Number of subjects: 120
Study 34215981 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum β‐hCG level measured in mIU/ml
Number of subjects: 120
Study 33221700 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-enriched fish oil (860 mg DHA + 120 g EPA/day)
Number of subjects: 61
Study 33221700 — intervention group
Group type: COMPARATOR
Intervention: Corn oil (isocaloric control)
Number of subjects: 61
Study 33221700 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-enriched fish oil
Number of subjects: 61
Study 35959802 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmon milt (SM) DNA for 12 weeks
Number of subjects: 50
Study 35959802 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 33780888 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Project condition
Number of subjects: 141
Study 33780888 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only condition
Number of subjects: 141
Study 32859272 — intervention group
Group type: EXPERIMENTAL
Intervention: Couple-based treatment
Number of subjects: 1332
Study 32859272 — intervention group
Group type: COMPARATOR
Intervention: Individual treatment
Number of subjects: 1332
Study 35477483 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 60
Study 35477483 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture (SEA)
Number of subjects: 60
Study 34106211 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichoptic training under noise-free conditions
Number of subjects: 116
Study 34106211 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichoptic training on all tasks
Number of subjects: 116
Study 34106211 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichoptic training
Number of subjects: 116
Study 34106211 — intervention group
Group type: COMPARATOR
Intervention: No training group
Number of subjects: 116
Study 33663491 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (education for GPs about pain management in AOM)
Number of subjects: 224
Study 33663491 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 224
Study 36175973 — intervention group
Group type: EXPERIMENTAL
Intervention: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP)
Number of subjects: 123
Study 36175973 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation intervention
Number of subjects: 123
Study 36175973 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 123
Study 33494781 — intervention group
Group type: EXPERIMENTAL
Intervention: burst SCS paradigm
Number of subjects: 60
Study 33494781 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 kHz SCS paradigm
Number of subjects: 60
Study 33494781 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.499 kHz SCS paradigm
Number of subjects: 60
Study 33494781 — intervention group
Group type: COMPARATOR
Intervention: placebo stimulation
Number of subjects: 60
Study 32234756 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with gemcitabine (Gem)
Number of subjects: 101
Study 32234756 — intervention group
Group type: COMPARATOR
Intervention: Observation only (Obs)
Number of subjects: 101
Study 35868334 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (one daily subcutaneous injection uptitrated from 0.6-1.8 mg per day over 3 weeks)
Number of subjects: 52
Study 35868334 — intervention group
Group type: COMPARATOR
Intervention: Colesevelam (three capsules of 625 mg twice daily)
Number of subjects: 52
Study 35868334 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 52
Study 35868334 — intervention group
Group type: COMPARATOR
Intervention: Colesevelam
Number of subjects: 52
Study 34754004 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacists' interventions (education and follow-up plan)
Number of subjects: 131
Study 34754004 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pharmacist intervention)
Number of subjects: 131
Study 32682483 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 798
Study 32682483 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 798
Study 34798039 — intervention group
Group type: EXPERIMENTAL
Intervention: Etrolizumab (n=384)
Number of subjects: 609
Study 34798039 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=95)
Number of subjects: 609
Study 34798039 — intervention group
Group type: EXPERIMENTAL
Intervention: Etrolizumab to etrolizumab (n=117)
Number of subjects: 609
Study 34798039 — intervention group
Group type: COMPARATOR
Intervention: Etrolizumab to placebo (n=115)
Number of subjects: 609
Study 34798039 — intervention group
Group type: EXPERIMENTAL
Intervention: Etrolizumab (induction)
Number of subjects: 609
Study 34798039 — intervention group
Group type: COMPARATOR
Intervention: Placebo (induction)
Number of subjects: 609
Study 34798039 — intervention group
Group type: EXPERIMENTAL
Intervention: Etrolizumab to etrolizumab (maintenance)
Number of subjects: 609
Study 34798039 — intervention group
Group type: COMPARATOR
Intervention: Etrolizumab to placebo (maintenance)
Number of subjects: 609
Study 34158575 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese children (n=150)
Number of subjects: 681
Study 34158575 — intervention group
Group type: COMPARATOR
Intervention: Non-obese children (n=531)
Number of subjects: 681
Study 36274797 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Peres' height formula (height of patient (cm)/10-2)
Number of subjects: 400
Study 36274797 — intervention group
Group type: COMPARATOR
Intervention: Distance between puncture site and right third intercostal space (PS‐RTICS) - 1
Number of subjects: 400
Study 33882206 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacituzumab govitecan
Number of subjects: 468
Study 33882206 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (eribulin, vinorelbine, capecitabine, or gemcitabine)
Number of subjects: 468
Study 33955109 — intervention group
Group type: EXPERIMENTAL
Intervention: HER2−/HR+ in EBC
Number of subjects: 6977
Study 33955109 — intervention group
Group type: EXPERIMENTAL
Intervention: HER2+ in EBC
Number of subjects: 6977
Study 33955109 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple negative in EBC
Number of subjects: 6977
Study 33955109 — intervention group
Group type: EXPERIMENTAL
Intervention: HER2−/HR+ in MBC
Number of subjects: 6977
Study 33955109 — intervention group
Group type: EXPERIMENTAL
Intervention: HER2+ in MBC
Number of subjects: 6977
Study 33955109 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple negative in MBC
Number of subjects: 6977
Study 35227152 — intervention group
Group type: EXPERIMENTAL
Intervention: No stoma
Number of subjects: 54
Study 35227152 — intervention group
Group type: COMPARATOR
Intervention: Stoma
Number of subjects: 54
Study 33227549 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation (lower smoking burden score)
Number of subjects: 726
Study 33227549 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking burden score (SBS)
Number of subjects: 726
Study 33227549 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline cigarettes per day (CPD)
Number of subjects: 726
Study 33227549 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 726
Study 33227549 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation
Number of subjects: 726
Study 34887446 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 0
Study 34887446 — intervention group
Group type: COMPARATOR
Intervention: Non-chemotherapy
Number of subjects: 0
Study 32145372 — intervention group
Group type: EXPERIMENTAL
Intervention: Go/No-go training for highly palatable (HP) food
Number of subjects: 561
Study 32145372 — intervention group
Group type: COMPARATOR
Intervention: General inhibitory control (control group)
Number of subjects: 561
Study 37592484 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogel perirectal spacer (SpaceOAR® system)
Number of subjects: 222
Study 37592484 — intervention group
Group type: COMPARATOR
Intervention: Fiducial markers alone (control group)
Number of subjects: 222
Study 33904667 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (20 mg)
Number of subjects: 19
Study 33904667 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 32588671 — intervention group
Group type: COMPARATOR
Intervention: 595-nm pulsed dye laser (control group)
Number of subjects: 194
Study 32588671 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential therapy with 755-nm long-pulsed alexandrite laser and 595-nm pulsed dye laser (experimental group)
Number of subjects: 194
Study 33160115 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 574
Study 33160115 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 574
Study 33810258 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab + vitamin-D
Number of subjects: 40
Study 33810258 — intervention group
Group type: COMPARATOR
Intervention: Placebo-infliximab + vitamin-D
Number of subjects: 40
Study 35415743 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Skills intervention (instructional lessons, peer modeling videos, behavioral scaffolding, structured activities)
Number of subjects: 72
Study 35415743 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Skills intervention
Number of subjects: 72
Study 35415743 — intervention group
Group type: COMPARATOR
Intervention: Free Play (control group)
Number of subjects: 72
Study 34265088 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD 10 mg/kg/day (CBD10)
Number of subjects: 318
Study 34265088 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD 20 mg/kg/day (CBD20)
Number of subjects: 318
Study 34265088 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 318
Study 34265088 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD (combined CBD10 and CBD20)
Number of subjects: 318
Study 32523337 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital-outreach pulmonary rehabilitation program
Number of subjects: 208
Study 32523337 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 208
Study 33740048 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet (LFD)
Number of subjects: 100
Study 33740048 — intervention group
Group type: COMPARATOR
Intervention: Traditional dietary advice (TDA)
Number of subjects: 100
Study 32396038 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates program (36 weeks, twice weekly)
Number of subjects: 12
Study 35399836 — intervention group
Group type: EXPERIMENTAL
Intervention: Family nursing service intervention
Number of subjects: 150
Study 34172505 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine care plus phone-based weekly pill refilling and daily medication reminders
Number of subjects: 306
Study 34172505 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 306
Study 32428227 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous theta-burst transcranial magnetic stimulation to the dorsal inferior parietal lobule (dIPL)
Number of subjects: 0
Study 32428227 — intervention group
Group type: COMPARATOR
Intervention: Baseline dIPL-M1 and aIPL-M1 cortico-cortical interactions
Number of subjects: 0
Study 32428227 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortical silent period measurement
Number of subjects: 0
Study 32428227 — intervention group
Group type: EXPERIMENTAL
Intervention: dIPL-PMv resting state functional connectivity
Number of subjects: 0
Study 32428227 — intervention group
Group type: COMPARATOR
Intervention: Baseline PMv-M1 interactions
Number of subjects: 0
Study 34655304 — intervention group
Group type: EXPERIMENTAL
Intervention: Penile skin graft (PSG)
Number of subjects: 100